Hospira has announced the US re-launch of oxaliplatin injection, a generic version of Sanofi's chemotherapy medication Eloxatin. Hospira will initially offer the solution form of oxaliplatin injection in 50mg and 100mg single-use vials, ...
Tags: oxaliplatin injection, Sanofi's chemotherapy medication, oncology drug
Hospira has entered into a definitive agreement to purchase Orchid Chemicals&Pharmaceuticals'FDA-approved active pharmaceutical ingredient(API)manufacturing and Chennai-based R&D facilities for approximately$200m. The acquisition will ...
Tags: Orchid Chemicals, Hospira, active pharmaceutical ingredient
Mylan Institutional has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Etomidate Injection USP, 2 mg/mL packaged in 40 mg/20 mL single-use vials. The approved ...
Tags: Medicine, Etomidate Injection, Hospira's Amidate injection
Hospira has recalled 9 lots of cancer drugs including carboplatin, cytarabine, paclitaxel, and methotrexate packaged in vials in the US. The recall, which is based on the appearance of visible particles embedded in the glass located at ...
Tags: Recall, Cancer Drug, FDA